1. Home
  2. RDNT vs RYTM Comparison

RDNT vs RYTM Comparison

Compare RDNT & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$72.40

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$112.68

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDNT
RYTM
Founded
1985
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.4B
IPO Year
1986
2017

Fundamental Metrics

Financial Performance
Metric
RDNT
RYTM
Price
$72.40
$112.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
13
Target Price
$83.60
$125.77
AVG Volume (30 Days)
837.5K
887.7K
Earning Date
11-09-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,969,599,000.00
$174,334,000.00
Revenue This Year
$11.77
$47.34
Revenue Next Year
$10.76
$57.18
P/E Ratio
N/A
N/A
Revenue Growth
11.09
54.92
52 Week Low
$45.00
$45.91
52 Week High
$85.84
$122.20

Technical Indicators

Market Signals
Indicator
RDNT
RYTM
Relative Strength Index (RSI) 37.42 58.29
Support Level $74.96 $109.59
Resistance Level $79.67 $122.20
Average True Range (ATR) 3.07 5.23
MACD -0.87 1.08
Stochastic Oscillator 19.10 56.83

Price Performance

Historical Comparison
RDNT
RYTM

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: